These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12560823)

  • 1. Lymphoma market turf war imminent, pending Bexxar approval.
    Garber K
    Nat Biotechnol; 2003 Feb; 21(2):115-6. PubMed ID: 12560823
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunotherapy and NHL: nuclear medicine on the oncology team.
    Knight N
    J Nucl Med; 2002 Apr; 43(4):11N-12N, 25N, passim. PubMed ID: 11963928
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma.
    Schaefer-Cutillo J; Friedberg JW; Fisher RI
    Oncology (Williston Park); 2007 Feb; 21(2):203-12; discussion 214, 217, 221. PubMed ID: 17396483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coulter, SmithKline agree to develop anti-B1 antibody.
    Oncologist; 1999; 4(1):84-5. PubMed ID: 10337377
    [No Abstract]   [Full Text] [Related]  

  • 5. A new weapon in the treatment of non-Hodgkin's lymphoma.
    Lipcamon JD; Sahl B
    Radiol Manage; 2002; 24(5):13-5. PubMed ID: 12422657
    [No Abstract]   [Full Text] [Related]  

  • 6. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 7. Ibritumomab tiuxetan (Zevalin) for non-Hodgkin's lymphoma.
    Med Lett Drugs Ther; 2002 Nov; 44(1144):101-2. PubMed ID: 12494494
    [No Abstract]   [Full Text] [Related]  

  • 8. StatBite: Avastin Quarterly Sales, 2009-2011.
    J Natl Cancer Inst; 2011 Aug; 103(15):1149. PubMed ID: 21768533
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphoma treatment approved.
    AIDS Patient Care STDS; 1998 Mar; 12(3):231. PubMed ID: 11361944
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunotherapy of non-Hodgkin's lymphoma: clinical development of the Zevalin regimen.
    Theuer CP; Leigh BR; Multani PS; Allen RS; Liang BC
    Biotechnol Annu Rev; 2004; 10():265-95. PubMed ID: 15504711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 13. The therapeutic monoclonal antibody market.
    Ecker DM; Jones SD; Levine HL
    MAbs; 2015; 7(1):9-14. PubMed ID: 25529996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
    Kaminski MS; Armitage JO
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-54-8. PubMed ID: 23570101
    [No Abstract]   [Full Text] [Related]  

  • 15. Thumbs up for Avastin.
    Spalding BJ
    Nat Biotechnol; 2008 Apr; 26(4):365. PubMed ID: 18392003
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphoma.
    Schaefer-Cutillo J; Friedberg JW
    Semin Hematol; 2008 Apr; 45(2):110-7. PubMed ID: 18381106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ODAC panel gives nod to Bexxar.
    Garber K
    J Natl Cancer Inst; 2003 Feb; 95(3):189. PubMed ID: 12569139
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioimmunotherapy with tositumomab and iodine-131 tositumomab for low-grade non-Hodgkin lymphoma: nursing implications.
    Estes JM; Clapp KJ
    Oncol Nurs Forum; 2004 Nov; 31(6):1119-26. PubMed ID: 15547634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of Non-Hodgkin's lymphoma.
    Britton KE
    J Nucl Med; 2004 May; 45(5):924-5. PubMed ID: 15136647
    [No Abstract]   [Full Text] [Related]  

  • 20. A revolution in the treatment of non-Hodgkin's lymphoma.
    DeNardo GL; O'Donnell RT; Oldham RK; DeNardo SJ
    Cancer Biother Radiopharm; 1998 Aug; 13(4):213-23. PubMed ID: 10850358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.